Amphotericin B-conjugated polypeptide hydrogels as a novel innovative strategy for fungal infections.

about

Amphotericin B-conjugated polypeptide hydrogels as a novel innovative strategy for fungal infections.

Item

http://www.wikidata.org/entity/Q52587125

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Amphotericin B-conjugated poly ...... trategy for fungal infections.

@en

Amphotericin B-conjugated poly ...... trategy for fungal infections.

@nl

type

Item

label

Amphotericin B-conjugated poly ...... trategy for fungal infections.

@en

Amphotericin B-conjugated poly ...... trategy for fungal infections.

@nl

prefLabel

Amphotericin B-conjugated poly ...... trategy for fungal infections.

@en

Amphotericin B-conjugated poly ...... trategy for fungal infections.

@nl

P1476

Amphotericin B-conjugated poly ...... strategy for fungal infections

@en

P2093

Duo Li

http://www.w3.org/2001/XMLSchema#string

Li Ding

http://www.w3.org/2001/XMLSchema#string

Shunli Ji

http://www.w3.org/2001/XMLSchema#string

Tengfei Li

http://www.w3.org/2001/XMLSchema#string

Wen Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Dephosphorylation of D-peptide derivatives to form biofunctional, supramolecular nanofibers/hydrogels and their potential applications for intracellular imaging and intratumoral chemotherapy.

A new form of amphotericin B - the complex with copper (II) ions - downregulates sTNFR1 shedding and changes the activity of genes involved in TNF-induced pathways: AmB-Cu2+ downregulates sTNFR1 shedding and changes the activity of genes involved in

Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.

Arginine-assisted immobilization of silver nanoparticles on ZnO nanorods: an enhanced and reusable antibacterial substrate without human cell cytotoxicity.

Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity.

Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting.

Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.

Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis.

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient.

Biophysical and molecular docking approaches for the investigation of biomolecular interactions between amphotericin B and bovine serum albumin.

P304

171814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1098/RSOS.171814

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chang Shu

P577

2018-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29657786

http://www.w3.org/2001/XMLSchema#string

P921

hydrogel

P932

5882710

http://www.w3.org/2001/XMLSchema#string